Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
42 studies found for:    Open Studies | "Hypertriglyceridemia"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell Lymphoma
Conditions: Hypertriglyceridemia;   Cutaneous T Cell Lymphoma
Intervention: Other: oral glucose tolerance test (OGTT)
2 Recruiting Hypertriglyceridaemia - Cause and Effects
Condition: Hypertriglyceridaemia
Intervention:
3 Unknown  Fish Oil Supplementation and Vascular Function in Hypertensive Patients With Hypertriglyceridemia
Conditions: Hypertension;   Hypertriglyceridemia
Interventions: Dietary Supplement: DHA-EPA;   Drug: Ciprofibrate
4 Recruiting The COMPASS Study: A Study of ISIS-APOCIIIRx in Patients With Hypertriglyceridemia
Condition: Hypertriglyceridemia
Interventions: Drug: ISIS APOCIIIRx;   Drug: Placebo
5 Unknown  Triglyceride Lowering Study
Condition: Hypertriglyceridemia
Intervention: Drug: Omega-3-Acid Ethyl Esters
6 Unknown  Omega-3 Fatty Acid Supplementation in Children
Conditions: Chronic Kidney Disease;   Hypertriglyceridemia
Interventions: Dietary Supplement: n-3 Fatty Acid supplement;   Dietary Supplement: Placebo
7 Recruiting Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome
Conditions: Acute Coronary Syndrome;   Diabetes Mellitus, Type 2;   Hypertriglyceridemia
Interventions: Drug: Fenofibrate;   Drug: Simvastatin
8 Unknown  Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides
Condition: Hypertriglyceridemia
Interventions: Drug: 290 mg DCCR;   Drug: 435 mg DCCR;   Drug: 135 mg fenofibric acid;   Drug: Placebo;   Drug: atorvastatin
9 Recruiting Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia
Condition: Hypertriglyceridemia
Interventions: Drug: ARI-3037MO;   Drug: Placebo
10 Not yet recruiting The Efficacy of EPA+DHA (SC401B) for Lowering Triglyceride Levels (≥ 500 mg/dL)
Condition: Severe Hypertriglyceridemia
Interventions: Drug: Placebo;   Drug: SC401B 2 capsules;   Drug: SC401B 4 capsules;   Drug: SC401B 6 capsules
11 Unknown  Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.
Conditions: Insulin Resistance;   Hypertriglyceridemia
Interventions: Drug: Rosiglitazone;   Drug: Fenofibrate;   Behavioral: Weight Loss
12 Recruiting PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA
Conditions: Diabetes Mellitus, Non-Insulin-Dependent;   Hypertriglyceridemia
Interventions: Drug: Metformin Eicosapentaenoate;   Drug: Metformin HCl and Vascepa
13 Recruiting Bioavailability of EPA and DHA From Two Dietary Supplements
Condition: Hypertriglyceridemia
Intervention: Dietary Supplement: DHA-rich fish oil versus Phospholipid-rich fish oil
14 Unknown  Fructose Consumption and Metabolic Dysregulation
Conditions: Central Obesity;   Hypertriglyceridemia
Intervention: Dietary Supplement: Fructose
15 Recruiting Efficacy of LCQ908 on Cardiovascular Risk
Conditions: Coronary Artery Disease;   Hypertriglyceridemia
Interventions: Drug: LCQ908;   Drug: Placebo
16 Recruiting A Pilot Study to Evaluate the Lipid Effects of TRIA-662
Conditions: Hypertriglyceridemia;   Mixed Hyperlipidemia
Interventions: Drug: TRIA-662;   Drug: Placebo
17 Unknown  Effects of DPP-4 Inhibition on Triglycerides
Conditions: Type 2 Diabetes;   Hypertriglyceridemia
Intervention: Drug: Saxagliptin
18 Recruiting Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease
Conditions: Non Alcoholic Fatty Liver Disease;   Steatohepatitis;   Hypertriglyceridemia;   Alanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1
Interventions: Dietary Supplement: Lovaza;   Other: Omega diet
19 Unknown  Lovaza Mechanisms of Action
Condition: Moderate Hypertriglyceridemia.
Intervention: Dietary Supplement: Omega 3 fatty acid (Lovaza)
20 Unknown  Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline
Condition: Hypertriglyceridemia
Interventions: Drug: Diazoxide choline;   Drug: Diazoxide choline high dose

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years